AlphaGrep UK’s Insmed INSM Stock Holding History

AlphaGrep UK’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$442K	Buy	3,873 +1,062	+38%	+$125K	0.13%	308
2026 Q2	$300K	Buy	+2,811	New	+$340K	0.09%	474

Other funds holding INSM

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

AlphaGrep UK's INSM Position: Q3 2026 in Review

AlphaGrep UK increased its Insmed (INSM) stake by 38% in Q3 2026, buying an estimated $125K and bringing the position to 3,873 shares worth $442K. The position accounts for 0.13% of the portfolio, ranked #308.

AlphaGrep UK first reported a position in INSM in Q2 2026 and has held it in 2 quarters since. 547 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

AlphaGrep UK held 3,873 shares of Insmed worth $442K as of Q3 2026.
AlphaGrep UK bought 1,062 Insmed shares in Q3 2026, an estimated $125K.
Insmed made up 0.13% of AlphaGrep UK's portfolio in Q3 2026, its #308 holding.
AlphaGrep UK first reported a position in Insmed in Q2 2026 and has held it in 2 quarters since.
547 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.